paul from edi, page-19

Did I miss something or is SBN not a specky Biotech play.

I hold more stock in SBN than 90% of the posters on the SBN thread combined excluding the position of maybe a couple of posters.

This stock everyone is and has only ever been a punt, granted one that theoretically has the potential for massive rewards but thats why it's a punt. Small biotechs trying to make it are without fail the story of failure due to the fact it's one of the hardest industries to succeed in. Govt regulations, trials, FDAs, standards, etc are a nightmare. Relatively speaking SBN are plodding along fine, not perfect but fine.

Lets have some perspective guys this aint a blue chip and if you could not afford to loss the lot on such a specky trade you should not have invested.

In my opinion SBN is worth a punt.